within Pharmacolibrary.Drugs.ATC.D;

model D06BB12
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D06BB12</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sinecatechins is a botanical drug extracted from green tea (Camellia sinensis) and contains a mixture of catechins. It is primarily used topically for the treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent adults. Sinecatechins ointment is FDA-approved and marketed under the brand name Veregen.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic model parameters for sinecatechins are reported in published literature as the drug is administered topically and systemic absorption is negligible. Data on plasma concentrations, bioavailability, volume of distribution, clearance, or absorption rates are not available.</p><h4>References</h4><ol><li><p>Stockfleth, E, &amp; Meyer, T (2012). The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts. <i>Expert opinion on biological therapy</i> 12(6) 783–793. DOI:<a href=\"https://doi.org/10.1517/14712598.2012.676036\">10.1517/14712598.2012.676036</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22506983/\">https://pubmed.ncbi.nlm.nih.gov/22506983</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D06BB12;
